Am Law Firms Beat Back Class Cert Bid in Pharma Case

, The Litigation Daily

   | 0 Comments

Siding with lawyers at Kaye Scholer and Munger Tolles, a federal judge declined to certify two classes in an antitrust case accusing a Pfizer subsidiary of conspiring to block cheaper generic versions of its Skelaxin muscle relaxant from reaching the market.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202641051258

Thank you!

This article's comments will be reviewed.